Published in AIDS Weekly, September 9th, 1996
The terms of the accelerated approval require additional clinical trials to confirmed reported findings and investigated whether somatotropin improves patients' physical performance. Since December of 1994, more than 300 patients have already received Serostim under a treatment IND. Serono Laboratories, Inc., Randolph, Massachusetts, has agreed to distribute the drug.
The findings of an earlier trial indicated that patients treated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.